http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5995289-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 1982-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa60d88d2ba55246568e9dbbf7a4d6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e44748a4cf8f9276f7d8cb3c380fd80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afececc18bee22d8b85daeda00959ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4241d33b44ec6c3b25a2424a6b05c2e |
| publicationDate | 1984-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S5995289-A |
| titleOfInvention | Triazolopyrimidine derivative, its preparation, and drug containing it as active ingredient |
| abstract | NEW MATERIAL:A compound shown by the formula I [X 1 WX 3 are H, halogen, lower alkyl, lower alkoxy(carbonyl), carboxyl, OH, amino, nitro, or trifluoromethyl; R 1 is H, -CO 2 R 7 (R 7 is 1W6C alkyl); R 2 is -NR 8 R 9 , -NHNR 8 R 9 (R 8 and R 9 are H, 1W6C alkyl, etc.); when R 1 is H, R 3 and R 4 , and R 5 and R 6 are linked to form single bond, respctively; when R 1 is -CO 2 R 7 , R 3 and R 4 , and R 5 and R 6 are linked to form single bond, respectively, or R 3 and R 6 are H, and R 4 and R 5 are linked to form single bond, or R 3 and R 4 are linked to form single bond, and R 5 and R 6 are H]. n EXAMPLE: 7-( o-Chlorophenyl )-6-ethoxylcarbonyl-4, 5, 6, 7-tetrahydro-5-oxo[1, 2, 4] triazolo[1,5-a]pyrimidine. n USE: A remedy for diseases of circulatory organs. n PROCESS: A 5-halotriazolopyrimidine derivative shown by the formula II (Y is halogen) is reacted with an amino compound shown by the formula NR 5 R 9 or a hydrazino compound shown by the formula HNHNR 8 R 9 . n COPYRIGHT: (C)1984,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2623502-A1 |
| priorityDate | 1982-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.